True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India

Background: A significant number of safe donations are removed from the blood supply, because of the reactive anti-HCV screening test results. This study aimed to assess if the HCV (Hepatitis C Virus) seropositive donors were confirmed positive or not. Materials and Methods: More than 68,000 blood d...

Full description

Bibliographic Details
Main Authors: Sunita Tulsiani, Nabajyoti Choudhury, Priti Desai, Ripal Shah, Ankit Mathur, V Harimoorthy, Jwalant Shah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:http://www.ajts.org/article.asp?issn=0973-6247;year=2012;volume=6;issue=2;spage=165;epage=168;aulast=Tulsiani
_version_ 1818276692095926272
author Sunita Tulsiani
Nabajyoti Choudhury
Priti Desai
Ripal Shah
Ankit Mathur
V Harimoorthy
Jwalant Shah
author_facet Sunita Tulsiani
Nabajyoti Choudhury
Priti Desai
Ripal Shah
Ankit Mathur
V Harimoorthy
Jwalant Shah
author_sort Sunita Tulsiani
collection DOAJ
description Background: A significant number of safe donations are removed from the blood supply, because of the reactive anti-HCV screening test results. This study aimed to assess if the HCV (Hepatitis C Virus) seropositive donors were confirmed positive or not. Materials and Methods: More than 68,000 blood donors′ samples were routinely screened and 140 samples were found to be anti-HCV ELISA reactive. These 140 samples were tested by NAT. The NAT negative samples were tested by RIBA. Analysis of samples reactive in single ELISA kit vs. two ELISA kits was done. Results: Out of 140 anti-HCV ELISA reactive samples, a total of 16 (11.43%) were positive by NAT. The results of 124 RIBA showed 6 (4.84%) positive, 92 (74.19%) negative, and 26 (20.97%) indeterminate results. None of the sample which was reactive in only single ELISA kit was positive by NAT or RIBA. Conclusion: Only a minority of blood donors with repeatedly reactive anti-HCV screening test is positive by confirmatory testing, but all these blood units are discarded as per existing legal provisions in India. Efforts should be made to retain these donors and also donor units.
first_indexed 2024-12-12T22:49:41Z
format Article
id doaj.art-0c1ad369aece428faaa96ee578d44fe8
institution Directory Open Access Journal
issn 0973-6247
1998-3565
language English
last_indexed 2024-12-12T22:49:41Z
publishDate 2012-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj.art-0c1ad369aece428faaa96ee578d44fe82022-12-22T00:09:06ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652012-01-016216516810.4103/0973-6247.98927True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western IndiaSunita TulsianiNabajyoti ChoudhuryPriti DesaiRipal ShahAnkit MathurV HarimoorthyJwalant ShahBackground: A significant number of safe donations are removed from the blood supply, because of the reactive anti-HCV screening test results. This study aimed to assess if the HCV (Hepatitis C Virus) seropositive donors were confirmed positive or not. Materials and Methods: More than 68,000 blood donors′ samples were routinely screened and 140 samples were found to be anti-HCV ELISA reactive. These 140 samples were tested by NAT. The NAT negative samples were tested by RIBA. Analysis of samples reactive in single ELISA kit vs. two ELISA kits was done. Results: Out of 140 anti-HCV ELISA reactive samples, a total of 16 (11.43%) were positive by NAT. The results of 124 RIBA showed 6 (4.84%) positive, 92 (74.19%) negative, and 26 (20.97%) indeterminate results. None of the sample which was reactive in only single ELISA kit was positive by NAT or RIBA. Conclusion: Only a minority of blood donors with repeatedly reactive anti-HCV screening test is positive by confirmatory testing, but all these blood units are discarded as per existing legal provisions in India. Efforts should be made to retain these donors and also donor units.http://www.ajts.org/article.asp?issn=0973-6247;year=2012;volume=6;issue=2;spage=165;epage=168;aulast=TulsianiAnti-Hepatitis C Virus Enzyme-linked immunosorbent assaynucleic acid amplification testrecombinant immuno blot assay
spellingShingle Sunita Tulsiani
Nabajyoti Choudhury
Priti Desai
Ripal Shah
Ankit Mathur
V Harimoorthy
Jwalant Shah
True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India
Asian Journal of Transfusion Science
Anti-Hepatitis C Virus Enzyme-linked immunosorbent assay
nucleic acid amplification test
recombinant immuno blot assay
title True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India
title_full True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India
title_fullStr True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India
title_full_unstemmed True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India
title_short True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India
title_sort true positivity of anti hepatitis c virus enzyme linked immunosorbent assay reactive blood donors a prospective study done in western india
topic Anti-Hepatitis C Virus Enzyme-linked immunosorbent assay
nucleic acid amplification test
recombinant immuno blot assay
url http://www.ajts.org/article.asp?issn=0973-6247;year=2012;volume=6;issue=2;spage=165;epage=168;aulast=Tulsiani
work_keys_str_mv AT sunitatulsiani truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia
AT nabajyotichoudhury truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia
AT pritidesai truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia
AT ripalshah truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia
AT ankitmathur truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia
AT vharimoorthy truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia
AT jwalantshah truepositivityofantihepatitiscvirusenzymelinkedimmunosorbentassayreactiveblooddonorsaprospectivestudydoneinwesternindia